With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Molecular Signature of Inflammation||Medical College of Wisconsin / Subramaniam Malarkannan, PhD||Springboard Grants||2013||Wisconsin|
|Theranostics in Children and Young Adults||University of Iowa / Sue O'Dorisio, MD, PhD||Springboard Grants||2013||Iowa|
|Phase II Trial of Poly-ICLC in Pediatric Low Grade Gliomas||University of California, San Diego / Donald Durden, MD, PhD||Springboard Grants||2013||California|
|Function of the PR Domain of the MDSI-EVI1 in MLL Fusion Protein Leukemogenesis||University of Rochester / Archibald Perkins, MD, PhD||Springboard Grants||2013||New York|
|Develop a Therapeutic Vaccine Approach by Removing Viral Immune Evasion||University of California, Los Angeles / Ren Sun, PhD||Springboard Grants||2013||California|
|Inflammatory Signaling in the Tumor Microenvironment||St. Jude Children's Research Hospital / Peter J. Murray, PhD||Springboard Grants||2013||Tennessee|
|Modeling Genetic Modifiers of Down Syndrome Leukemogenesis||Children's Hospital of Philadelphia / Stella T. Chou, MD||Springboard Grants||2013||Pennsylvania|
|Preclinical Development of Targeted Therapy for Neuroblastoma with ALK and CDK4/6 Dual Pathway Inhibition||Children's Hospital of Philadelphia / Yael Mossé, MD||Reach Grants||2013||Pennsylvania|
|B-lapachone as a Novel Targeted Therapy for ATRTs and other Pediatric Cancers||University of Texas Southwestern Medical Center / James Amatruda, MD, PhD||Reach Grants||2013||Texas|
|Combining Oncolytic Vaccinia Virus with GD2.CAR-modified Vaccinia Virus-specific T-cells for the Treatment of Relapsed Neuroblastoma and Sarcoma||Baylor College of Medicine / Cliona Rooney, PhD||Reach Grants||2013||Texas|